Post-approval studies (Phase 4)Study completedNCT00121381
What this trial is testing
Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis
Who this might be right for
Dermatitis, Atopic
Novartis 400